These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 15355810

  • 21. Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.
    Esposito V, Di Biase S, Lettiero T, Labella D, Simeone R, Salerno M.
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):607-11. PubMed ID: 15521964
    [Abstract] [Full Text] [Related]

  • 22. Serum lipid profiles including non-high density lipoprotein cholesterol levels in Turkish school-children.
    Uçar B, Kiliç Z, Dinleyici EC, Colak O, Güneş E.
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):415-20. PubMed ID: 18065339
    [Abstract] [Full Text] [Related]

  • 23. Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting.
    Bullano MF, Wertz DA, Yang GW, Kamat S, Borok GM, Gandhi S, McDonough KL, Willey VJ.
    Pharmacotherapy; 2006 Apr; 26(4):469-78. PubMed ID: 16553504
    [Abstract] [Full Text] [Related]

  • 24. Association of serum lipid profiles with depressive and anxiety disorders in menopausal women.
    Chen CC, Huang TL.
    Chang Gung Med J; 2006 Apr; 29(3):325-30. PubMed ID: 16924895
    [Abstract] [Full Text] [Related]

  • 25. Oat-derived beta-glucan significantly improves HDLC and diminishes LDLC and non-HDL cholesterol in overweight individuals with mild hypercholesterolemia.
    Reyna-Villasmil N, Bermúdez-Pirela V, Mengual-Moreno E, Arias N, Cano-Ponce C, Leal-Gonzalez E, Souki A, Inglett GE, Israili ZH, Hernández-Hernández R, Valasco M, Arraiz N.
    Am J Ther; 2007 Apr; 14(2):203-12. PubMed ID: 17414591
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Influence of apolipoprotein E genotype on the reliability of the Friedewald formula in the estimation of low-density lipoprotein cholesterol concentrations.
    Tremblay AJ, Bergeron J, Gagné JM, Gagné C, Couture P.
    Metabolism; 2005 Aug; 54(8):1014-9. PubMed ID: 16092050
    [Abstract] [Full Text] [Related]

  • 28. Lipoprotein profile and prevalence of cardiovascular risk factors in urban Moroccan women.
    El ayachi M, Mziwira M, Vincent S, Defoort C, Portugal H, Lairon D, Belahsen R.
    Eur J Clin Nutr; 2005 Dec; 59(12):1379-86. PubMed ID: 16118656
    [Abstract] [Full Text] [Related]

  • 29. Calculated low density lipoprotein cholesterol levels frequently underestimate directly measured low density lipoprotein cholesterol determinations in patients with serum triglyceride levels < or =4.52 mmol/l: an analysis comparing the LipiDirect magnetic LDL assay with the Friedewald calculation.
    Tighe DA, Ockene IS, Reed G, Nicolosi R.
    Clin Chim Acta; 2006 Mar; 365(1-2):236-42. PubMed ID: 16259972
    [Abstract] [Full Text] [Related]

  • 30. Effects of xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with stable angina.
    Li JJ, Hu SS, Fang CH, Hui RT, Miao LF, Yang YJ, Gao RL.
    Clin Chim Acta; 2005 Feb; 352(1-2):217-24. PubMed ID: 15653117
    [Abstract] [Full Text] [Related]

  • 31. Acute coffee ingestion does not affect LDL cholesterol level.
    Cheung RJ, Gupta EK, Ito MK.
    Ann Pharmacother; 2005 Feb; 39(7-8):1209-13. PubMed ID: 15928258
    [Abstract] [Full Text] [Related]

  • 32. [Evaluation of selected risk factors of atherosclerosis in children with type 1 diabetes mellitus and hypercholesterolemia].
    Muchacka-Bianga M, Deja G, Jarosz-Chobot P, Małecka-Tendera E, Kalina M, Grychtoł M.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006 Feb; 12(1):25-30. PubMed ID: 16704858
    [Abstract] [Full Text] [Related]

  • 33. Significance of dyslipidaemia in patients with heart failure of unexplained aetiology.
    Skwarek M, Bilińska ZT, Mazurkiewicz Ł, Grzybowski J, Kruk M, Kurjata P, Piotrowski W, Ruzyłło W.
    Kardiol Pol; 2008 May; 66(5):515-22, discussion 523-4. PubMed ID: 18537059
    [Abstract] [Full Text] [Related]

  • 34. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T, Denke M, McBride P, Battisti WP, Brady WE, Palmisano J.
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [Abstract] [Full Text] [Related]

  • 35. Serum lipid levels in Sjögren's syndrome.
    Lodde BM, Sankar V, Kok MR, Leakan RA, Tak PP, Pillemer SR.
    Rheumatology (Oxford); 2006 Apr; 45(4):481-4. PubMed ID: 16303821
    [Abstract] [Full Text] [Related]

  • 36. Assessment of lipid dysfunction in patients on maintenance haemodialysis.
    Altaf A, Halim A, Khan DA, Khalid M, Fatima-Tuz-Zuhra, Saif I.
    J Ayub Med Coll Abbottabad; 2007 Apr; 19(4):32-6. PubMed ID: 18693593
    [Abstract] [Full Text] [Related]

  • 37. Lipid levels and cardiovascular risk in elderly women: a general population study of the effects of hormonal treatment and lipid-lowering agents.
    Dupuy AM, Carrière I, Scali J, Cristol JP, Ritchie K, Dartigues JF, Gambert P, Ancelin ML.
    Climacteric; 2008 Feb; 11(1):74-83. PubMed ID: 18202967
    [Abstract] [Full Text] [Related]

  • 38. A simplified precise method for adjusting serum levels of persistent organohalogen pollutants to total serum lipids.
    Rylander L, Nilsson-Ehle P, Hagmar L.
    Chemosphere; 2006 Jan; 62(3):333-6. PubMed ID: 16005493
    [Abstract] [Full Text] [Related]

  • 39. False negative results in the Roche assay for HDL-cholesterol.
    Bakker AJ, Zijlstra A, Leemhuis MP.
    Ann Clin Biochem; 2003 Sep; 40(Pt 5):572-5. PubMed ID: 14503999
    [Abstract] [Full Text] [Related]

  • 40. Characterization of a new potent heparin. 4th communication: The effect of a new potent heparin preparation on lipid components and leucocytes in rats after subcutaneous application.
    Bhargava AS, Staben P, Schöbel C, Günzel P.
    Arzneimittelforschung; 1980 Sep; 30(9):1562-6. PubMed ID: 7193025
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.